Dilly Ashok-Kumar, Tang Keqin, Guo Yande, Joshi Sangeeta, Ekambaram Prasanna, Maddipati Krishna Rao, Cai Yinlong, Tucker Stephanie C, Honn Kenneth V
Departments of Pathology-Bioactive Lipids Research Program, Detroit, MI 48202, United States.
Departments of Radiation Oncology, Wayne State University School of Medicine, Detroit, MI 48202, United States.
Exp Cell Res. 2017 Feb 1;351(1):1-10. doi: 10.1016/j.yexcr.2016.12.011. Epub 2016 Dec 20.
12-Lipoxygenase (12-LOX) metabolizes arachidonic acid to 12(S)-hydroxyeicosatetraenoic acid, or 12(S)-HETE, a proinflammatory bioactive lipid implicated in tumor angiogenesis, growth, and metastasis. The mechanisms underlying 12-LOX-mediated signaling in cancer progression are still ill-defined. In the present study we demonstrate that 12-LOX phosphorylation and subsequent enzymatic activity occurs after integrin β4 stimulation and Src kinase recruitment to the integrin subunit. Inhibition of Src activity by PP2 or Src dominant-negative mutants reduced 12-LOX tyrosine phosphorylation and 12(S)-HETE production in response to integrin β4 stimulation in A431 cells. The pertinent Src-targeted residues for 12-LOX activity were mapped to Y19 and Y614, where 12-LOX mutants Y19F and Y614F showed 70% less enzymatic activity. Furthermore, we have shown that the 12-LOX activity modulated by these residues impacts migration. To our knowledge, this is the first report that c-Src kinase activity is required for β4-integrin-mediated phosphorylation of 12-LOX.
12-脂氧合酶(12-LOX)将花生四烯酸代谢为12(S)-羟基二十碳四烯酸,即12(S)-HETE,一种参与肿瘤血管生成、生长和转移的促炎生物活性脂质。12-LOX介导的信号传导在癌症进展中的潜在机制仍不明确。在本研究中,我们证明12-LOX磷酸化及随后的酶活性在整合素β4刺激和Src激酶募集到整合素亚基后发生。用PP2或Src显性负性突变体抑制Src活性可降低A431细胞中整合素β4刺激后12-LOX的酪氨酸磷酸化和12(S)-HETE的产生。12-LOX活性相关的Src靶向残基定位于Y19和Y614,其中12-LOX突变体Y19F和Y614F的酶活性降低了70%。此外,我们还表明,由这些残基调节的12-LOX活性会影响迁移。据我们所知,这是第一份关于c-Src激酶活性是β4整合素介导的12-LOX磷酸化所必需的报告。